93 related articles for article (PubMed ID: 27259665)
41. CD24, a glycosylphosphatidylinositol-anchored molecules is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors.
Poncet C; Frances V; Gristina R; Scheiner C; Pellissier JF; Figarella-Branger D
Acta Neuropathol; 1996; 91(4):400-8. PubMed ID: 8928617
[TBL] [Abstract][Full Text] [Related]
42. The evolution of gene expression levels in mammalian organs.
Brawand D; Soumillon M; Necsulea A; Julien P; Csárdi G; Harrigan P; Weier M; Liechti A; Aximu-Petri A; Kircher M; Albert FW; Zeller U; Khaitovich P; Grützner F; Bergmann S; Nielsen R; Pääbo S; Kaessmann H
Nature; 2011 Oct; 478(7369):343-8. PubMed ID: 22012392
[TBL] [Abstract][Full Text] [Related]
43. CD24 expression predicts poor prognosis for patients with cutaneous malignant melanoma.
Tang MR; Wang YX; Guo S; Han SY; Li HH; Jin SF
Int J Clin Exp Med; 2014; 7(11):4337-41. PubMed ID: 25550951
[TBL] [Abstract][Full Text] [Related]
44. Behavioral Characterizing of CD24 Knockout Mouse-Cognitive and Emotional Alternations.
Nitzan K; Toledano R; Shapira S; Arber N; Doron R
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33562144
[TBL] [Abstract][Full Text] [Related]
45. Deep sequencing of mRNA in CD24(-) and CD24(+) mammary carcinoma Mvt1 cell line.
Rostoker R; Jayaprakash AD; Sachidanandam R; LeRoith D
Genom Data; 2015 Sep; 5():399-401. PubMed ID: 26484297
[TBL] [Abstract][Full Text] [Related]
46. Measuring gene expression divergence: the distance to keep.
Glazko G; Mushegian A
Biol Direct; 2010 Aug; 5():51. PubMed ID: 20691088
[TBL] [Abstract][Full Text] [Related]
47. Nano-LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec-10 Signaling Pathway.
Wang K; Yu A; Liu K; Feng C; Hou Y; Chen J; Ma S; Huang L; Dai X
Adv Sci (Weinh); 2023 Sep; 10(26):e2305364. PubMed ID: 37712353
[No Abstract] [Full Text] [Related]
48. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
Barkal AA; Brewer RE; Markovic M; Kowarsky M; Barkal SA; Zaro BW; Krishnan V; Hatakeyama J; Dorigo O; Barkal LJ; Weissman IL
Nature; 2019 Aug; 572(7769):392-396. PubMed ID: 31367043
[TBL] [Abstract][Full Text] [Related]
49. The CD24 surface antigen in neural development and disease.
Gilliam DT; Menon V; Bretz NP; Pruszak J
Neurobiol Dis; 2017 Mar; 99():133-144. PubMed ID: 27993646
[TBL] [Abstract][Full Text] [Related]
50. Novel insights into the function of CD24: A driving force in cancer.
Altevogt P; Sammar M; Hüser L; Kristiansen G
Int J Cancer; 2021 Feb; 148(3):546-559. PubMed ID: 32790899
[TBL] [Abstract][Full Text] [Related]
51. Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10.
Yin SS; Gao FH
Front Immunol; 2020; 11():1324. PubMed ID: 32765491
[TBL] [Abstract][Full Text] [Related]
52. CD24: A Rheostat That Modulates Cell Surface Receptor Signaling of Diverse Receptors.
Ayre DC; Christian SL
Front Cell Dev Biol; 2016; 4():146. PubMed ID: 28083532
[No Abstract] [Full Text] [Related]
53. Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal-maternal interface.
Sammar M; Siwetz M; Meiri H; Fleming V; Altevogt P; Huppertz B
Histochem Cell Biol; 2017 May; 147(5):565-574. PubMed ID: 28012129
[TBL] [Abstract][Full Text] [Related]
54. CD24: A Novel Target for Cancer Immunotherapy.
Panagiotou E; Syrigos NK; Charpidou A; Kotteas E; Vathiotis IA
J Pers Med; 2022 Jul; 12(8):. PubMed ID: 36013184
[TBL] [Abstract][Full Text] [Related]
55. CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemia and Lymphoma: Current Insights.
Christian SL
Onco Targets Ther; 2022; 15():1391-1402. PubMed ID: 36425299
[TBL] [Abstract][Full Text] [Related]
56. Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy.
Eyvazi S; Kazemi B; Dastmalchi S; Bandehpour M
Curr Cancer Drug Targets; 2018; 18(4):328-336. PubMed ID: 28820056
[TBL] [Abstract][Full Text] [Related]
57. Checkpoint CD24 function on tumor and immunotherapy.
Huang S; Zhang X; Wei Y; Xiao Y
Front Immunol; 2024; 15():1367959. PubMed ID: 38487533
[TBL] [Abstract][Full Text] [Related]
58. Surprising magic of CD24 beyond cancer.
Wang H; Shi P; Shi X; Lv Y; Xie H; Zhao H
Front Immunol; 2023; 14():1334922. PubMed ID: 38313430
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
